INTRODUCTION/OBJECTIVES: Studies comparing the effects of antiarrhythmic protocols used for rate control in dogs with secondary atrial fibrillation (AF) are currently limited
therefore, this study aimed to report detailed data on the efficacy and therapy-related side-effects (TRSEs) of different antiarrhythmic protocols in dogs with secondary AF. ANIMALS, MATERIALS, AND METHODS: Dogs with secondary AF treated with combination therapy with diltiazem and digoxin (CT RESULTS: Fifty-four dogs were included, with 28 receiving the CT DISCUSSION: In dogs with secondary AF we included, CT LIMITATIONS: Retrospective design
heterogeneous sample size of categories analyzed
clinicopathological data available for many, but not all, dogs. CONCLUSIONS: Our findings support the indication to generally consider CT